LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC
Abstract Background Dysregulation of transcription and cytokine expression has been implicated in the pathogenesis of a variety inflammatory diseases. The resulting imbalance between inflammatory and resolving transcriptional programs can cause an overabundance of pro-inflammatory, classically activ...
Main Authors: | Gregory Thomas, Elizabeth Frederick, Lisa Thompson, Raphael Bar-Or, Yetti Mulugeta, Melissa Hausburg, Michael Roshon, Charles Mains, David Bar-Or |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-020-02626-z |
Similar Items
-
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
by: Gregory Thomas, et al.
Published: (2020-05-01) -
ZINC DEFICIENCY AND MECHANISMS OF ENDOTHELIAL CELL DYSFUNCTION
by: Shen, Huiyun
Published: (2008) -
Role of NF-kB RelB in Aryl Hydrocarbon Receptor-Mediated Ligand Specific Effects
by: Yasuhiro Ishihara, et al.
Published: (2019-05-01) -
Potential Health-modulating Effects of Isoflavones and Metabolites via Activation of PPAR and AhR
by: Alois Jungbauer, et al.
Published: (2010-02-01) -
PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2005-03-01)